Search

Your search keyword '"Delmas, D"' showing total 242 results

Search Constraints

Start Over You searched for: Author "Delmas, D" Remove constraint Author: "Delmas, D"
242 results on '"Delmas, D"'

Search Results

201. Inhibition of cancer derived cell lines proliferation by synthesized hydroxylated stilbenes and new ferrocenyl-stilbene analogs. Comparison with resveratrol.

202. Stilbenes and resveratrol metabolites improve mitochondrial fatty acid oxidation defects in human fibroblasts.

203. Differential protective effects of red wine polyphenol extracts (RWEs) on colon carcinogenesis.

204. Mechanisms of ceramide-induced COX-2-dependent apoptosis in human ovarian cancer OVCAR-3 cells partially overlapped with resveratrol.

205. Importance of lipid microdomains, rafts, in absorption, delivery, and biological effects of resveratrol.

206. Resveratrol metabolites inhibit human metastatic colon cancer cells progression and synergize with chemotherapeutic drugs to induce cell death.

207. Absence of correlation between oxysterol accumulation in lipid raft microdomains, calcium increase, and apoptosis induction on 158N murine oligodendrocytes.

208. Natural polyphenols properties: chemopreventive and chemosensitizing activities.

209. Immunomodulation and anti-inflammatory roles of polyphenols as anticancer agents.

210. A moderate red wine intake improves blood lipid parameters and erythrocytes membrane fluidity in post myocardial infarct patients.

211. α-Tocopherol impairs 7-ketocholesterol-induced caspase-3-dependent apoptosis involving GSK-3 activation and Mcl-1 degradation on 158N murine oligodendrocytes.

212. Role of membrane dynamics processes and exogenous molecules in cellular resveratrol uptake: consequences in bioavailability and activities.

213. Endocytosis of resveratrol via lipid rafts and activation of downstream signaling pathways in cancer cells.

214. Pro-apoptotic versus anti-apoptotic properties of dietary resveratrol on tumoral and normal cardiac cells.

215. Structural basis for the potential antitumour activity of DNA-interacting benzo[kl]xanthene lignans.

216. What is new for an old molecule? Systematic review and recommendations on the use of resveratrol.

217. Transport, stability, and biological activity of resveratrol.

218. Resveratrol modulates the levels of microRNAs targeting genes encoding tumor-suppressors and effectors of TGFβ signaling pathway in SW480 cells.

219. Resveratrol decreases the levels of miR-155 by upregulating miR-663, a microRNA targeting JunB and JunD.

220. Structural determinants of resveratrol for cell proliferation inhibition potency: experimental and docking studies of new analogs.

221. Changes in care and outcome of very preterm babies in the Parisian region between 1998 and 2003.

222. Effects of resveratrol analogs on cell cycle progression, cell cycle associated proteins and 5fluoro-uracil sensitivity in human derived colon cancer cells.

223. Sonolysis of levodopa and paracetamol in aqueous solutions.

224. Effects of endocrine disruptors on genes associated with 17beta-estradiol metabolism and excretion.

225. Antiproliferative activities of resveratrol and related compounds in human hepatocyte derived HepG2 cells are associated with biochemical cell disturbance revealed by fluorescence analyses.

226. Inhibitory effects of trans-resveratrol analogs molecules on the proliferation and the cell cycle progression of human colon tumoral cells.

227. Risk factors for not delivering in a level III unit before 32 weeks of gestation: results from a population-based study in Paris and surrounding districts in 2003.

228. Resveratrol in human hepatoma HepG2 cells: metabolism and inducibility of detoxifying enzymes.

229. Resveratrol as a chemopreventive agent: a promising molecule for fighting cancer.

230. Current concepts in the evaluation and management of stress fractures.

231. Sideline documentation and its role in return to sport.

232. Synthesis and antileishmanial activities of 4,5-di-substituted acridines as compared to their 4-mono-substituted homologues.

233. Resveratrol: preventing properties against vascular alterations and ageing.

234. Overuse injuries in equestrian athletes.

236. Redistribution of CD95, DR4 and DR5 in rafts accounts for the synergistic toxicity of resveratrol and death receptor ligands in colon carcinoma cells.

237. Transport of resveratrol, a cancer chemopreventive agent, to cellular targets: plasmatic protein binding and cell uptake.

238. Human hepatic cell uptake of resveratrol: involvement of both passive diffusion and carrier-mediated process.

239. Resveratrol-induced apoptosis is associated with Fas redistribution in the rafts and the formation of a death-inducing signaling complex in colon cancer cells.

240. Molecular analysis on the chemopreventive properties of resveratrol, a plant polyphenol microcomponent.

241. [Regulation of bacterial proteolytic activity at natural concentrations in dissolved organic matter in a maritime pond].

Catalog

Books, media, physical & digital resources